$MDSO News

Last published 5y ago

5y agoPHR MDSO SAPPhreesia Announces Planned CFO Transition in 2021: Chief Financial Officer Tom Altier to Retire, Randy Rasmussen Named New CFOBusiness WireNEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) today announced that Tom Altier, its Chief Financial Officer, will retire in April 2021. Randy Rasmussen, the company’s Chief Accounting Officer, will succeed Altier as CFO, effective May 1, 2021. Altier, who joined Phreesia in 2012, will continue in his current role through the end of April 2021 and the filing of Phreesia’s Annual Report on Fo ...
7y agoMDSODassault Systèmes Completes Acquisition of Medidata Opening Up a New World of Virtual Twin Experiences for HealthcareGlobeNewswireThe 3DEXPERIENCE Platform combines modeling, simulation, data science, artificial intelligence and collaboration in the virtual world to achieve sustainable innovation in life sciencesDassault...
7y agoMDSODassault Systèmes Completes Acquisition of Medidata Opening Up a New World of Virtual Twin Experiences for HealthcareBusiness WireVELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Dassault Systèmes (Paris:DSY) (Euronext Paris: #13065, DSY.PA) today announced the completion of its acquisition of Medidata Solutions, Inc. (NASDAQ: MDSO), whose clinical expertise and cloud-based solutions power the smarter development and commercialization of treatments. The acquisition positions Dassault Systèmes to lead the digital transformation ...
7y agoMDSODassault Systèmes announces CFIUS clearance for Medidata acquisitionGlobeNewswireVÉLIZY-VILLACOUBLAY, France and NEW YORK, United States of America — October 24, 2019 – Dassault Systèmes SE ("Dassault Systèmes") (Euronext Paris: #13065, DSY. PA) and Medidata Solutions, Inc....
7y agoMDSOMedidata Introduces Study Site Analytics, New Feature for Sites to Receive Real-Time Performance Metrics and BenchmarksBusiness WireNEW YORK--(BUSINESS WIRE)--FDA inspections continue to highlight recurring issues with site performance throughout the past ten years. To prevent performance issues, sites rely on actionable performance information prior to preparing for regulatory inspection. According to a Society of Clinical Research Sites (SCRS) white paper survey:
7y agoMDSOForbes Names Medidata CEO to “America’s Most Innovative Leaders” ListBusiness WireNEW YORK--(BUSINESS WIRE)--Forbes named Tarek Sherif, CEO of Medidata (NASDAQ: MDSO), to their list of “America’s Most Innovative Leaders.” Mr. Sherif ranked among today’s top 100 most creative and successful business minds.
7y agoMDSOFor Precision Medicine to Achieve Its Potential, Life Science Leaders Embrace New Data and AI ModelsBusiness WireNEW YORK--(BUSINESS WIRE)--Eighty-four percent of senior life science executives agree that precision medicine represents a new era in drug development, according to the Newsweek Vantage report, Precision Medicine: Creating Value for Everyone. Sponsored by Medidata (NASDAQ: MDSO), Thermo Fisher Scientific, and Bristol-Myers Squibb, the survey report highlights the need for data-centric, AI tools a ...
7y agoMDSOMedidata and Mapi Research Trust (MRT) Announce Strategic Collaboration to Standardize eCOA Global Library of QuestionnairesBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) and Mapi Research Trust today announced a new critical mission: to build a digital, global library of pre-configured and pre-approved eCOA (clinical outcomes assessment) questionnaires. The collaboration will create reusable versions of MRT distributed questionnaires in Medidata Rave eCOA, collecting COA data from hundreds of studies each year on ...
7y agoMDSOMedidata Reports Second Quarter 2019 ResultsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced its financial results for the second quarter of 2019.
7y agoMDSOMedidata Announces Second Quarter 2019 Earnings DateBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced that it will release its second quarter 2019 results after the close of U.S. financial markets on Tuesday, July 23, 2019. Due to the company's pending acquisition by Dassault Systèmes, it will not host a conference call to discuss its results.
7y agoMDSOCatalyst Launches New Multi-solution CRO Powered by the Medidata Rave Clinical Cloud™Business WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced today that Catalyst Clinical Research chose the Medidata Rave Clinical Cloud™ for its one-platform approach to clinical trials. By adopting Medidata Rave CTMS combined with Rave EDC and Rave eTMF, Catalyst immediately offers a data-driven, state-of-the-art unified clinical platform as it launches its new CRO full-service managed solution ...
7y agoMDSOTissueTech Expands its Clinical Program with Medidata’s End-to-end Unified PlatformBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced that TissueTech, Inc. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform for clinical trials. TissueTech recognizes this partnership as critical to helping spearhead the company’s transformation in biologics with a focus on regenerative therapies derived from human birth tissue for patients with serious unmet clinica ...
7y agoMDSOOrion Transforms its Clinical Trials with MedidataBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced that global pharmaceutical company Orion will consolidate all clinical trials on the Medidata Rave Clinical Cloud™ and expand its use of trial management solutions to support growth of its R&D pipeline.
7y agoMDSODassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation For Patient-Centric Experience Through End-to-End Collaborative PlatformBusiness WireVÉLIZY-VILLACOUBLAY, France & NEW YORK--(BUSINESS WIRE)--Dassault Systèmes (Euronext Paris: #13065, DSY.PA) and Medidata Solutions, Inc. (NASDAQ: MDSO), leader of the digital transformation of the Life Sciences industry for clinical development, commercial, and real-world data intelligence, today announced the signing of a definitive agreement for Dassault Systèmes to acquire Medidata in an all-ca ...
7y agoMDSOMedidata to Present at Jefferies Healthcare ConferenceBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019, at 9 a.m. ET in New York.
7y agoMDSOSHYFT Expands Real-World Evidence Solutions Empowering Life Sciences to Make Better Value-Based DecisionsBusiness WireWALTHAM, Mass.--(BUSINESS WIRE)--SHYFT Analytics, a Medidata company (NASDAQ: MDSO), today announced that it has significantly enhanced the real-world evidence (RWE) components of its solution platform. This expansion includes the appointment of key leadership positions that allow the company to cater to a broader range of life science organizations, including large biopharma companies, emerging b ...
7y agoMDSOMedidata to Present at Upcoming Investor ConferencesBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.
7y agoMDSOMedidata Reports Fourth Quarter 2018 ResultsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter of 2018.
7y agoMDSO CTSHMedidata and Cognizant Form Strategic Alliance to Make Digital Transformation Accessible for the Life SciencesBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) and Cognizant (NASDAQ:CTSH) have entered into a strategic alliance to offer life science clients comprehensive solutions that leverage the market’s leading cloud platform with world-class business and technology services. This provides pharmaceutical, biotech, medical device companies, contract research organizations (CROs), sites and investigators ...
7y agoMDSOMedidata Announces Fourth Quarter 2018 Earnings Conference CallBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced that it will release its fourth quarter 2018 financial results before the market opens on Tuesday, February 12, 2019. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results and business outlook.
7y agoMDSOMedidata Joins the World Economic ForumBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that it has entered into a three-year strategic collaboration with the World Economic Forum. The company becomes a Partner Member Associate and will participate in the WEF System Initiative focused on Shaping the Future of Health and Healthcare.
7y agoMDSOMedidata Introduces New Collaborative Workspace for Sites, Sponsors, and CROs to Manage TMF ContentBusiness WireNEW YORK--(BUSINESS WIRE)--Over 35 percent of inspections are delayed because the TMF is not complete or readily available1. To enable efficient, real-time collaboration on TMF documents between sponsors, CROs and sites, Medidata (NASDAQ:MDSO) today introduced a new workspace feature of its eTMF solution.
7y agoMDSOMedidata Named Best Workplace in Technology by Great Place to Work® and FORTUNEBusiness WireNEW YORK--(BUSINESS WIRE)--Great Place to Work and FORTUNE named Medidata (NASDAQ:MDSO) one of the 2019 Best Workplaces in Technology. The company was selected 25th among large companies.
7y agoMDSOMedidata Appoints Industry Leader Sastry Chilukuri as Executive Vice President of Digital and AI SolutionsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its senior leadership team.
7y agoMDSOMedidata to Present at the 37th Annual J.P. Morgan Healthcare ConferenceBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chairman and chief executive officer, and Rouven Bergmann, chief financial officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco at 4 p.m. PT (7 p.m. ET).
7y agoMDSOCala Health Streamlines Data and Operational Management for Neurological Device Study with Medidata CloudBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that Cala Health, a neuromodulation platform company developing wearable therapies for chronic disease, is adopting the Medidata Cloud to centralize management of a large observational study.
7y agoMDSONo Need for End of Study CDs: Medidata Introduces NEW Rave Digital EOS Media DeliveryBusiness WireNEW YORK--(BUSINESS WIRE)--To ease and unify Rave End of Study (EOS) document management, Medidata (NASDAQ:MDSO) today introduced a new, automated function of Edge Regulatory Content Management (RCM). Triggered automatically from Rave EDC, the new Edge RCM feature organizes, distributes and retains EOS documents to maintain regulatory compliance and inspection readiness.
7y agoMDSOMedidata Rave Omics Collaboration Uncovers Novel Insights for Rare Disease ResearchBusiness WireNEW YORK--(BUSINESS WIRE)--The Castleman Disease Collaborative Network (CDCN) discovered new patient subgroups, based on previously unknown proteomic signatures, with Medidata’s Rave Omics, a machine learning-based solution. These discoveries provide novel insights into treatment response and potential new drug targets, highlighting the value of precision medicine.
7y agoMDSOMedidata Rave Engage Wins Scrip Award for Best Sponsor-Focused Technological Development in Clinical TrialsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) is pleased to announce that Rave Engage was recognized at the 2018 Scrip Awards as the "Best Technological Development in Clinical Trials - Tech Sponsor Focused." This marks the third consecutive Scrip Award win for the company.
7y agoMDSOFederal Court Rejects Veeva’s Attack on Medidata’s Theft of Trade Secret ClaimsBusiness WireNEW YORK--(BUSINESS WIRE)--The United States District Court for the Southern District of New York has rejected Veeva’s motion to dismiss Medidata’s complaint against Veeva for theft of trade secrets, the company announced today.
7y agoMDSOMedidata to Present at Upcoming Investor ConferencesBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced its participation in two upcoming investor conferences.
7y agoMDSOTwo Research Studies Supported by Medidata to be Presented at ASH 2018Business WireNEW YORK--(BUSINESS WIRE)--The Castleman Disease Collaborative Network (CDCN) will present results of a large-scale proteomics study of idiopathic multicentric Castleman disease (iMCD), supported by Medidata Rave Omics, at the 60th Annual Meeting of the American Society of Hematology. The CDCN will also share an overview of its poster presentation and abstract at the Medidata (NASDAQ: MDSO) booth ...
7y agoMDSOHengrui Pharma Partners with Medidata to Accelerate Global Drug ResearchBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced that Hengrui Pharma, one of China’s largest sponsors, recently adopted Medidata Cloud, the Intelligent Platform for Life Sciences, to accelerate global drug research.
8y agoMDSOPAREXEL and SHYFT Analytics Partner to Deliver Faster, More Dynamic Real-World Data StudiesBusiness WireWALTHAM, Mass.--(BUSINESS WIRE)--SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, and PAREXEL International, a leading innovator of global biopharmaceutical services, today announced that the companies have entered into a strategic partnership that establishes SHYFT’s technology as an integral part of PAREXEL’s foundation for Real-World Evidence (RWE) generation and outcomes research f ...
8y agoMDSO ERYPERYTECH Expands Use of Medidata Cloud to Centrally Manage All Data for Oncology TrialsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced that ERYTECH (Euronext: ERYP - Nasdaq: ERYP) expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to streamline clinical trial operations. The addition to Rave EDC of Rave RTSM, Rave Imaging, and Edge Site Payments will allow ERYTECH to improve trial site budgeting, provide data access in real time an ...
8y agoMDSOMedidata Honors 2018 Architects of Hope Award WinnersBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced the winners of the third annual Architects of Hope Awards. Eight companies were recognized for their innovative approaches to addressing global patient needs at the conclusion of the Medidata NEXT NYC customer and partner conference.
8y agoMDSOPharm-Olam Unifies Data on Medidata Cloud, Eliminating SilosBusiness WireNEW YORK--(BUSINESS WIRE)--Today at NEXT NYC, Medidata (NASDAQ:MDSO) announced that Pharm-Olam International (Pharm-Olam) signed a new, five-year enterprise agreement to unify operational systems supporting study execution on Medidata Cloud, the Intelligence Platform for Life Sciences.
8y agoMDSOMedidata Sets Major New Corporate Social Responsibility (CSR) CommitmentsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) is committed to creating a better world for patients. The company spent the past year building a corporate social responsibility program dedicated to STEM education, patient advocacy and global inclusion. Today Medidata announces several new pledges to further its commitment to these principles.
8y agoMDSODr. Jill Biden, National Minority Quality Forum, Global Sponsors and CROs Discuss the Future of Healthcare and Clinical Research at Medidata NEXT NYC 2018Business WireNEW YORK--(BUSINESS WIRE)--Medidata NEXT NYC, the premier conference on the digital transformation of life sciences, will feature keynotes from global sponsors and CROs, and Medidata (NASDAQ: MDSO). The customer conference runs from October 24-25 at Spring Studios in New York City.
8y agoMDSOMedidata Appoints Dr. Maria Rivas to its Board of DirectorsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) announced today that it has appointed Dr. Maria Rivas to its Board of Directors. An endocrinologist with extensive experience as a senior leader in the pharmaceutical industry, Dr. Rivas becomes the first woman to serve on the company’s board. This also marks her first public board appointment.
8y agoMDSOMedidata Reports Third Quarter 2018 ResultsBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018.
8y agoMDSOMedidata to Host Investor Day on October 24 in New YorkBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that it will hold its Investor Day on October 24, 2018 in New York.
8y agoMDSOMedidata Cloud Securely Manages Echocardiogram Images for Global Heart Measurement StudyBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that Medidata Cloud, the Intelligent Platform for Life Sciences, is streamlining the management of medical images for the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. WASE is the first study of its kind to measure heart dimension and function across countries, geographical regions, cultures, gender, an ...
8y agoMDSOIndustry Milestone: Over 15,000 Studies Have Run on Medidata Cloud PlatformBusiness WireNEW YORK--(BUSINESS WIRE)--More than 15,000 studies have been conducted on the Medidata Cloud, the Intelligent Platform for Life Sciences, Medidata (NASDAQ: MDSO) announced today, making it the industry’s largest data repository.
8y agoMDSOMedidata Announces Third Quarter 2018 Earnings Conference CallBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced that it will release its third quarter 2018 financial results before the market opens on Thursday, October 18, 2018. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results and business outlook.
8y agoMDSOMedidata and Decibel Therapeutics Announce Multi-Year Collaboration in Support of Clinical Development for Hearing Loss, Tinnitus, and Balance DisordersBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO) today announced that Decibel Therapeutics is adopting Medidata Cloud, the Intelligent Platform for Life Sciences. The agreement will support the Boston biotech company’s clinical development for hearing loss, tinnitus, and balance disorders.
8y agoMDSOMedidata Certified as a Great Place to Work®Business WireNEW YORK--(BUSINESS WIRE)--Medidata employees take great pride as “Medidatians,” according to the 2018 Great Place to Work® survey. This is the third consecutive year that Medidata (NASDAQ: MDSO) was certified as a great workplace by independent analysts.
8y agoMDSOMedidata to Present at Upcoming Investor ConferencesBusiness WireNEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.
8y agoMDSOHanmi to Streamline Clinical Trials and Bolster Quality of Results with Medidata CloudBusiness WireSEOUL, South Korea--(BUSINESS WIRE)--Hanmi expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to improve clinical trial efficiency and quality of results, Medidata (NASDAQ:MDSO) announced today. By adding Edge Central Monitoring and Rave eCOA/ePRO to its current use of Rave EDC, Hanmi will gain greater insight into clinical trial performance and mobile patient data ...
8y agoMDSOMedidata Selected for Fortune 100 Fastest-Growing Companies ListBusiness WireNEW YORK--(BUSINESS WIRE)--In recognition of three record-performing years, Medidata (NASDAQ: MDSO) was selected for Fortune’s 100 Fastest-Growing Companies list. Fortune ranked Medidata a top performer in consecutive years.